vs
Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and INSTEEL INDUSTRIES INC (IIIN). Click either name above to swap in a different company.
Axsome Therapeutics, Inc. is the larger business by last-quarter revenue ($196.0M vs $159.9M, roughly 1.2× INSTEEL INDUSTRIES INC). INSTEEL INDUSTRIES INC runs the higher net margin — 4.7% vs -14.6%, a 19.3% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs 23.3%). INSTEEL INDUSTRIES INC produced more free cash flow last quarter ($-2.2M vs $-18.7M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 12.0%).
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
Insteel Industries Inc is a leading U.S. manufacturer of steel reinforcing products including welded wire reinforcement and steel fibers. It primarily serves non-residential construction, infrastructure, and precast concrete segments across North America, delivering high-performance reinforcement solutions for various construction projects.
AXSM vs IIIN — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $196.0M | $159.9M |
| Net Profit | $-28.6M | $7.6M |
| Gross Margin | — | 11.3% |
| Operating Margin | -13.8% | 6.0% |
| Net Margin | -14.6% | 4.7% |
| Revenue YoY | 65.0% | 23.3% |
| Net Profit YoY | 61.9% | 602.4% |
| EPS (diluted) | $-0.55 | $0.39 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $196.0M | $159.9M | ||
| Q3 25 | $171.0M | $177.4M | ||
| Q2 25 | $150.0M | $179.9M | ||
| Q1 25 | $121.5M | $160.7M | ||
| Q4 24 | $118.8M | $129.7M | ||
| Q3 24 | $104.8M | $134.3M | ||
| Q2 24 | $87.2M | $145.8M | ||
| Q1 24 | $75.0M | $127.4M |
| Q4 25 | $-28.6M | $7.6M | ||
| Q3 25 | $-47.2M | $14.6M | ||
| Q2 25 | $-48.0M | $15.2M | ||
| Q1 25 | $-59.4M | $10.2M | ||
| Q4 24 | $-74.9M | $1.1M | ||
| Q3 24 | $-64.6M | $4.7M | ||
| Q2 24 | $-79.3M | $6.6M | ||
| Q1 24 | $-68.4M | $6.9M |
| Q4 25 | — | 11.3% | ||
| Q3 25 | — | 16.1% | ||
| Q2 25 | — | 17.1% | ||
| Q1 25 | — | 15.3% | ||
| Q4 24 | — | 7.3% | ||
| Q3 24 | — | 9.1% | ||
| Q2 24 | — | 10.6% | ||
| Q1 24 | — | 12.3% |
| Q4 25 | -13.8% | 6.0% | ||
| Q3 25 | -27.0% | 10.8% | ||
| Q2 25 | -24.5% | 11.0% | ||
| Q1 25 | -46.9% | 8.3% | ||
| Q4 24 | -61.1% | 1.1% | ||
| Q3 24 | -59.8% | 4.5% | ||
| Q2 24 | -89.5% | 6.0% | ||
| Q1 24 | -89.7% | 7.0% |
| Q4 25 | -14.6% | 4.7% | ||
| Q3 25 | -27.6% | 8.2% | ||
| Q2 25 | -32.0% | 8.4% | ||
| Q1 25 | -48.9% | 6.4% | ||
| Q4 24 | -63.1% | 0.8% | ||
| Q3 24 | -61.7% | 3.5% | ||
| Q2 24 | -91.0% | 4.5% | ||
| Q1 24 | -91.1% | 5.4% |
| Q4 25 | $-0.55 | $0.39 | ||
| Q3 25 | $-0.94 | $0.74 | ||
| Q2 25 | $-0.97 | $0.78 | ||
| Q1 25 | $-1.22 | $0.52 | ||
| Q4 24 | $-1.54 | $0.06 | ||
| Q3 24 | $-1.34 | $0.24 | ||
| Q2 24 | $-1.67 | $0.34 | ||
| Q1 24 | $-1.44 | $0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $322.9M | $15.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $88.3M | $358.8M |
| Total Assets | $689.8M | $456.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $322.9M | $15.6M | ||
| Q3 25 | $325.3M | $38.6M | ||
| Q2 25 | $303.0M | $53.7M | ||
| Q1 25 | $300.9M | $28.4M | ||
| Q4 24 | $315.4M | $36.0M | ||
| Q3 24 | $327.3M | $111.5M | ||
| Q2 24 | $315.7M | $97.7M | ||
| Q1 24 | $331.4M | $83.9M |
| Q4 25 | $88.3M | $358.8M | ||
| Q3 25 | $73.7M | $371.5M | ||
| Q2 25 | $73.1M | $356.2M | ||
| Q1 25 | $53.2M | $341.4M | ||
| Q4 24 | $57.0M | $331.6M | ||
| Q3 24 | $92.9M | $350.9M | ||
| Q2 24 | $102.9M | $346.0M | ||
| Q1 24 | $144.0M | $340.6M |
| Q4 25 | $689.8M | $456.1M | ||
| Q3 25 | $669.3M | $462.6M | ||
| Q2 25 | $639.8M | $471.9M | ||
| Q1 25 | $596.7M | $421.9M | ||
| Q4 24 | $568.5M | $404.7M | ||
| Q3 24 | $561.5M | $422.6M | ||
| Q2 24 | $548.2M | $414.6M | ||
| Q1 24 | $545.7M | $397.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.7M | $-701.0K |
| Free Cash FlowOCF − Capex | $-18.7M | $-2.2M |
| FCF MarginFCF / Revenue | -9.6% | -1.4% |
| Capex IntensityCapex / Revenue | 0.0% | 0.9% |
| Cash ConversionOCF / Net Profit | — | -0.09× |
| TTM Free Cash FlowTrailing 4 quarters | $-93.9M | $439.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-18.7M | $-701.0K | ||
| Q3 25 | $1.0M | $-17.0M | ||
| Q2 25 | $-32.4M | $28.5M | ||
| Q1 25 | $-43.4M | $-3.3M | ||
| Q4 24 | $-26.2M | $19.0M | ||
| Q3 24 | $-18.6M | $16.2M | ||
| Q2 24 | $-30.1M | $18.8M | ||
| Q1 24 | $-53.5M | $1.4M |
| Q4 25 | $-18.7M | $-2.2M | ||
| Q3 25 | $988.0K | $-18.7M | ||
| Q2 25 | $-32.4M | $26.9M | ||
| Q1 25 | $-43.7M | $-5.5M | ||
| Q4 24 | $-26.2M | $16.3M | ||
| Q3 24 | $-18.7M | $14.5M | ||
| Q2 24 | $-30.2M | $15.5M | ||
| Q1 24 | $-53.6M | $-580.0K |
| Q4 25 | -9.6% | -1.4% | ||
| Q3 25 | 0.6% | -10.6% | ||
| Q2 25 | -21.6% | 15.0% | ||
| Q1 25 | -36.0% | -3.5% | ||
| Q4 24 | -22.1% | 12.6% | ||
| Q3 24 | -17.9% | 10.8% | ||
| Q2 24 | -34.6% | 10.7% | ||
| Q1 24 | -71.4% | -0.5% |
| Q4 25 | 0.0% | 0.9% | ||
| Q3 25 | 0.0% | 1.0% | ||
| Q2 25 | 0.0% | 0.9% | ||
| Q1 25 | 0.3% | 1.4% | ||
| Q4 24 | 0.0% | 2.1% | ||
| Q3 24 | 0.1% | 1.3% | ||
| Q2 24 | 0.1% | 2.2% | ||
| Q1 24 | 0.1% | 1.5% |
| Q4 25 | — | -0.09× | ||
| Q3 25 | — | -1.17× | ||
| Q2 25 | — | 1.88× | ||
| Q1 25 | — | -0.32× | ||
| Q4 24 | — | 17.56× | ||
| Q3 24 | — | 3.48× | ||
| Q2 24 | — | 2.86× | ||
| Q1 24 | — | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXSM
Segment breakdown not available.
IIIN
| Welded Wire Reinforcement | $108.4M | 68% |
| PC Strand | $51.6M | 32% |
